Merck (MRK) Non-Current Debt (2009 - 2026)

Merck has disclosed Non-Current Debt across 18 years of filings, most recently posting $46.7 billion for Q1 2026.

• In Q1 2026, Non-Current Debt rose 39.39% year-over-year to $46.7 billion; the TTM figure through Mar 2026 stood at $46.7 billion (up 39.39% YoY), while the FY2025 annual figure was $46.8 billion, up 35.66% from the prior year.
• Non-Current Debt held at $46.7 billion in Q1 2026, from $46.8 billion in the prior quarter.
• Over the last five years, Non-Current Debt for MRK reached as high as $46.8 billion in Q4 2025 and fell as low as $28.1 billion in Q1 2023.
• The 5-year median for Non-Current Debt is $34.0 billion (2025), against an average of $34.3 billion.
• Annual changes were most pronounced in 2023 — Non-Current Debt fell 8.21% — and 2026, when it jumped 39.39%.
• A 5-year view of Non-Current Debt shows it stood at $28.7 billion in 2022, then advanced by 17.18% to $33.7 billion in 2023, then grew by 2.31% to $34.5 billion in 2024, then jumped by 35.66% to $46.8 billion in 2025, then dropped by 0.16% to $46.7 billion in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $46.7 billion, $46.8 billion, and $40.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.